TScan Therapeutics, Inc. logo

TScan Therapeutics, Inc.

8 Marks
Corp.
First Filed:Sep 20, 2018Latest Filed:May 5, 2026Address:830 Winter Street, Waltham, MA 02451, US

Portfolio Overview

Top Classes

Class 42
Software, IT Services & Scientific Research
7(88%)
Class 5
Pharmaceuticals
6(75%)

TTAB Proceedings

No litigation activity

Top Firms

Loading...

Trademark Portfolio

8 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
ALLOHA-2
ALLOHA-2
Trademark
Combined
PENDING
Owner:
Serial:99804481
Filed:May 5, 2026
Classes:5, 42
Description: Class 5: Cells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical T-cell receptor engineered preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for medical use in the treatment of cancer
Class 42: Pharmaceutical research and development in the field of T-cell therapy for the treatment of cancer; T-cell therapy research services, namely, pharmaceutical and scientific research in the field of treatment of cancer using T-cell receptor engineered T-cell therapies
ALLOHA-2
ALLOHA-2
Trademark
Word
PENDING
Owner:
Serial:99804476
Filed:May 5, 2026
Classes:5, 42
Description: Class 5: Cells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical T-cell receptor engineered preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for medical use in the treatment of cancer
Class 42: Pharmaceutical research and development in the field of T-cell therapy for the treatment of cancer; T-cell therapy research services, namely, pharmaceutical and scientific research in the field of treatment of cancer using T-cell receptor engineered T-cell therapies
PLEXI-T
PLEXI-T
Trademark
Word
PENDING
Owner:
Serial:98705565
Filed:Aug 19, 2024
Classes:5, 42
Description: Cells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for use in the treatment of cancer; Pharmaceutical research and development in the nature of T-cell therapy for the treatment of cancer; T-cell therapy, namely pharmaceutical and scientific research for the treatment of cancer
ALLOHA
ALLOHA
Trademark
Word
PENDING
Owner:
Serial:98568310
Filed:May 24, 2024
Classes:5, 42
Description: Cells for medical or clinical use for use in the treatment of cancer; pharmaceutical and biopharmaceutical T-cell receptor engineered preparations for use in the treatment of cancer; T-cell therapy products, namely, T-cell receptor engineered cells for medical use in the treatment of cancer; Pharmaceutical research and development in the field of T-cell therapy for the treatment of cancer; T-cell therapy research services, namely, pharmaceutical and scientific research in the field of treatment of cancer using T-cell receptor engineered T-cell therapies
TSCAN THERAPEUTICS
TSCAN THERAPEUTICS
Trademark
Combined
REGISTERED
Owner:
Serial:97686190
Filed:Nov 21, 2022
Classes:5, 42
Registration:7250952
Registered:Dec 19, 2023
Description: Class 5: Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases and disorders, and inflammatory diseases and disorders
Class 42: Pharmaceutical research and development
TSCAN
TSCAN
Trademark
Word
REGISTERED
Owner:
Serial:97365551
Filed:Apr 15, 2022
Classes:5
Registration:7250537
Registered:Dec 19, 2023
Description: Pharmaceutical preparations for the prevention and treatment of cancer, autoimmune diseases and disorders, and inflammatory diseases and disorders
TSCAN
TSCAN
Service Mark
Word
REGISTERED
Owner:
Serial:88124712
Filed:Sep 20, 2018
Classes:42
Registration:6782631
Registered:Jul 5, 2022
Description: Pharmaceutical research and development
TSCAN THERAPEUTICS
TSCAN THERAPEUTICS
Service Mark
Combined
ABANDONED
Owner:
Serial:88124705
Filed:Sep 20, 2018
Classes:42
Description: "THERAPEUTICS"